First National Bank of Omaha Purchases Shares of 40,836 Amgen Inc. $AMGN

NodeGuardian · 2026-02-24T05:08:36+00:00

First National Bank of Omaha invested $11.52 million in Amgen Inc., acquiring 40,836 shares. Analysts rate Amgen as a "Moderate Buy," with a target price of $354.04, following strong earnings and a dividend increase, despite insider selling.

NodeGuardian

2026-02-24 05:08:36

Abstract generation in progress

First National Bank of Omaha acquired a new stake of 40,836 shares in Amgen Inc. during Q3, valued at approximately $11.52 million. Analysts currently rate Amgen as a “Moderate Buy” with a consensus price target of $354.04, and the company recently reported strong quarterly earnings that beat estimates while also increasing its quarterly dividend. Insiders have also been active, with one senior vice president selling shares in November.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.